PMID- 18252683
OWN - NLM
STAT- MEDLINE
DCOM- 20080220
LR  - 20190619
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 148
IP  - 3
DP  - 2008 Feb 5
TI  - Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. 
      Preventive Services Task Force recommendation statement.
PG  - 214-9
AB  - DESCRIPTION: Update of the 2001 U.S. Preventive Services Task Force (USPSTF) 
      recommendation on screening for bacterial vaginosis in pregnancy. METHODS: The 
      USPSTF weighed the benefits and harms of screening for bacterial vaginosis in 
      pregnancy by identifying new evidence addressing previously identified gaps from 
      the 2001 USPSTF recommendation. Published literature on this topic was identified 
      by using MEDLINE, Cochrane Library databases, the Database of Abstracts of 
      Reviews of Effects, reference lists, and consultation with experts and was 
      systematically reviewed. When data allowed, a series of meta-analyses (using new 
      and 2001 report data) was done to estimate the pooled effect of treatment on 
      preterm delivery (<37 weeks, <34 weeks, or <32 weeks) and on low birthweight and 
      preterm, premature rupture of membranes. RECOMMENDATION: Do not screen for 
      bacterial vaginosis in pregnant women at low risk for preterm delivery. (D 
      recommendation) RECOMMENDATION: Current evidence is insufficient to assess the 
      balance of benefits and harms of screening for bacterial vaginosis in pregnant 
      women at high risk for preterm delivery. (I statement).
CN  - U.S. Preventive Services Task Force
AD  - U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, 
      Rockville, Maryland, USA.
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
SB  - IM
CIN - Ann Intern Med. 2008 Feb 5;148(3):I30. PMID: 18252679
MH  - Female
MH  - Humans
MH  - *Mass Screening/adverse effects
MH  - Pregnancy
MH  - Pregnancy Complications, Infectious/*diagnosis/*drug therapy
MH  - Premature Birth/*prevention & control
MH  - Risk Factors
MH  - Vaginosis, Bacterial/*diagnosis/*drug therapy
EDAT- 2008/02/07 09:00
MHDA- 2008/02/21 09:00
CRDT- 2008/02/07 09:00
PHST- 2008/02/07 09:00 [pubmed]
PHST- 2008/02/21 09:00 [medline]
PHST- 2008/02/07 09:00 [entrez]
AID - 148/3/214 [pii]
AID - 10.7326/0003-4819-148-3-200802050-00007 [doi]
PST - ppublish
SO  - Ann Intern Med. 2008 Feb 5;148(3):214-9. doi: 
      10.7326/0003-4819-148-3-200802050-00007.